On November 18, 2026, the Center for Medical Device Evaluation (CMDE) of the National Medical Products Administration published a notice in China opening comments on 73 revised registration review guidelines for Class II medical devices, led by the Registration Review Guideline for Bone Tissue Surgical Equipment (2026 revision, draft for comments) (骨组织手术设备注册审查指导原则(2026年修订版)(征求意见稿)).
Manufacturers registering Class II bone-tissue surgical equipment in China, China registration agents of overseas makers of Class II devices covered by the 73 revised CMDE guidelines, domestic producers of the other Class II devices in that 73-item revision batch preparing NMPA registration or change filings, and testing laboratories compiling performance and clinical-evaluation files against those CMDE review guidelines must submit the CMDE comment form on the 73 draft revised Class II registration review guidelines by December 18, 2026, and align pending Class II registration dossiers with the revised review criteria for the product types in that batch, or comments filed after December 18, 2026 are outside the consultation, and a Class II registration dossier that does not match the revised CMDE review criteria can be queried or refused at technical review once the guidelines are used. Each comment goes to the contact named for that guideline, using the feedback form attached to the notice.
What did the November 18, 2026 CMDE notice put out for comment?
The November 18, 2026 notice puts 73 revised Class II registration review guidelines out as drafts for public comment, and it does not adopt them. A Class II medical device under State Council Order 739 is registered at provincial level in China, while a Class III device and every imported device is registered centrally with the NMPA. CMDE states that it organized the revision of the bone-tissue surgical equipment guideline (2026 revision, draft for comments) and 72 further Class II registration review guidelines, that the drafts are formed, and that comments are invited.
The webpage does not name the other 72 product types. They sit in Attachment 1. Attachment 2 is the feedback form. Attachment 3 maps each guideline to the contact who receives comments. Those three files are the working set for the window that closes on December 18, 2026.
| Attachment | Content | Use before December 18, 2026 |
|---|---|---|
| 1, archive | 73 draft revised Class II registration review guidelines, led by bone-tissue surgical equipment (2026 revision) | Identify which drafts cover the product types in a pending filing |
| 2, feedback form | Opinion feedback table | Record each comment against the draft it concerns |
| 3, contacts | Contact person for each guideline | Send the form to that contact |
Who has to read this 73-guideline batch?
The readers who have to act are the manufacturers registering Class II bone-tissue surgical equipment in China, the China registration agents of overseas makers whose Class II devices fall in the 73 revised guidelines, the domestic producers of the other Class II devices in that batch who are preparing a registration or a change filing, and the testing laboratories that compile performance and clinical-evaluation files against those review guidelines.
A registration review guideline is the criteria CMDE reviewers apply to a product type. This notice does not amend State Council Order No. 739 or the five-year validity of a Medical Device Registration Certificate. It changes the technical file a reviewer will expect for the product types in the batch, once the revised text is the one used at review. Obsidian tracks 15 regulatory texts, in force, amended or in preparation, for the Life Sciences & MedTech industry in China, as of November 2026.
What must be filed by December 18, 2026?
Comments must reach the named contact before December 18, 2026. The notice gives no later date and no extension.
- Open Attachment 1 and mark every draft whose product type matches a device you register, represent, manufacture, or test.
- Compare the performance indicators, clinical-evaluation route, and file structure in that draft with the dossier already in preparation.
- Complete Attachment 2, the feedback form, one row per point you want changed, kept, or clarified.
- Send the form to the contact in Attachment 3 so that it arrives by December 18, 2026.
- Where a pending Class II registration or change filing will be reviewed against the revised criteria, rewrite the mismatched sections before submission.
What happens if the comment is late or the dossier does not match?
A comment sent after December 18, 2026 is outside this consultation. The notice states no fine and no other sanction for a late or missing comment. The registration consequence is separate: once reviewers use the revised guideline, a Class II dossier that does not match those criteria can be queried or refused at technical review.
The query or refusal lands on the registrant and, for an overseas maker, on the China registration agent who files in that maker's name. Keep the sent feedback form with the transmission date. Continuous, per-jurisdiction monitoring surfaces a CMDE consultation of this kind when the notice is published.
Check whether any of the 73 drafts names your product type, file the feedback form with the Attachment 3 contact by December 18, 2026, and align any pending Class II dossier with the revised criteria before technical review. The notice is the CMDE publication of November 18, 2026.


